CapsoVision GAAP EPS of -$2.02 misses by $1.91, revenue of $3.32M beats by $0.07M

* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20201913-capsovision-reports-second-quarter-2025-financial-results] (NASDAQ:CV [https://seekingalpha.com/symbol/CV]): Q2 GAAP EPS of -$2.02 misses by $1.91.
* Revenue of $3.32M (+16.9% Y/Y) beats by $0.07M.
* New accounts grew 75% in the second quarter of 2025 over the comparable quarter in 2024.
* CapsoCam Plus® used by over 143,000 patients as of June 30, 2025.
* Cash and cash equivalents totaled $1.1 million as of June 30, 2025.

MORE ON CAPSOVISION, INC.

* CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology [https://seekingalpha.com/article/4791695-capsovision-proposes-ipo-terms-for-gi-tract-imaging-capsule-technology]
* CapsoVision prices $27.5M IPO [https://seekingalpha.com/news/4464600-capsovision-prices-275m-ipo]
* Historical earnings data for CapsoVision, Inc. [https://seekingalpha.com/symbol/CV/earnings]
* Financial information for CapsoVision, Inc. [https://seekingalpha.com/symbol/CV/income-statement]